Bonnie Henderson
Ophthalmology · Boston, MANPI 1710968953
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 35.1% of the total. Reporting peaked in 2019 at $89,192 and has fallen 99.7% since, to $286 in 2025. Among ophthalmology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $1501.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$98K
- Alcon$93K
- Alcon Research LLC$41K
- Novartis$26K
- AbbVie$8K
- Amgen$5K
- plus $8K from 15 others
What the payments were for
- Consulting fees$128,22046%
- Speaking & faculty fees$139,19250%
- Travel & lodging$6,9602%
- Food & beverage$4,9372%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 7 | $98,043 |
| Alcon | 92 | $93,181 |
| Alcon Research LLC | 16 | $41,019 |
| Novartis | 23 | $25,873 |
| AbbVie | 5 | $7,949 |
| Amgen | 5 | $5,481 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $1,574 |
| Carl Zeiss Meditec, Inc. | 1 | $1,500 |
| Eyepoint US, Inc. | 2 | $1,317 |
| Kala Pharmaceuticals, Inc. | 5 | $1,068 |
| Dompe US, Inc. | 3 | $821 |
| Aerie Pharmaceuticals, Inc. | 4 | $354 |
| Sun Pharmaceutical Industries Inc. | 4 | $240 |
| Sight Sciences, Inc. | 4 | $235 |
| Carl Zeiss Meditec USA, Inc. | 2 | $177 |
| Ivantis, Inc | 1 | $132 |
| Mallinckrodt Hospital Products Inc. | 1 | $118 |
| Genentech USA, Inc. | 1 | $117 |
| Oyster Point Pharma, Inc. | 1 | $89 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYZULTA$73,000
- MIEBO$62,500
- LOTEMAX SM$61,500
- AcrySof IQ PanOptix$21,502
- ORA$16,450
- AcrySof$14,000
- AcrySof IQ VIVITY IOL$11,352
- Capella Aberrometer$10,500
- DUREZOL$8,794
- ARGOS$5,715
- PROLENSA$5,500
- TEPEZZA$5,399
- SMART Suite$4,200
- STELLARIS$4,000
- RESTASIS$3,350
- LOTEMAX$1,500
- IOLMaster 700$1,500
- Centurion$1,400
- DEXYCU$1,317
- Oxervate$821
How this compares
$279,316 in reported general payments places this provider in the 95th percentile of 653 ophthalmology providers in Massachusetts.
Other ophthalmology in Boston
- Rishi SinghBoston$1.7M
- Adam RogersBoston$316K
- Dean EliottBoston$250K
- Mina FarahaniBoston$227K
- Jia YinBoston$173K
- John MillerBoston$106K
- Elizabeth RossinBoston$101K
- Suzanne FreitagBoston$96K
- Nimesh PatelBoston$94K
- Michael RaizmanBoston$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.